Again, the potential clinical relevance of these observations is shown by the similarly increased phosphorylation of histone 2AX and cleavage of PARP1, caspase 3 and caspase 9 in the T-cell lymphoma patient cell sample exposed to romidepsin (Figure 4b). This evidence concerns the gene CASP9 and T-cell non-Hodgkin lymphoma.